Myelodysplastic Syndromes
Showing NaN - NaN of 70
MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)
Not yet recruiting
- Myelodysplastic Syndromes
- Luspatercept
- Epoetin Alfa
-
Concord, California
- +100 more
Jul 20, 2023
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Marina Del Rey, California
- +35 more
Mar 11, 2022
MDS Trial in United States (Pracinostat, Azacitidine)
Terminated
- Myelodysplastic Syndromes
-
Duarte, California
- +24 more
Feb 4, 2022
MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)
Completed
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- Guadecitabine
- Treatment Choice
-
Duarte, California
- +95 more
Sep 1, 2021
Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)
Completed
- Hematologic Malignancy
- +4 more
-
Washington, District of Columbia
- +12 more
Jul 20, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
MDS Trial in Worldwide (Deferasirox, Placebo)
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)
Terminated
- Graft Versus Host Disease
- +2 more
- Fludarabine Phosphate
- +7 more
-
New Haven, Connecticut
- +1 more
Aug 10, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
MDS Trial in United States (azacitidine)
Completed
- Myelodysplastic Syndromes
-
Bakersfield, California
- +30 more
Nov 7, 2019
MDS Trial in Germany, United States (lenalidomide)
Completed
- Myelodysplastic Syndromes
-
Scottsdale, Arizona
- +31 more
Nov 6, 2019
MDS Trial in United States (Atezolizumab, Azacitidine)
Completed
- Myelodysplastic Syndromes
-
Duarte, California
- +14 more
Aug 15, 2019
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seattle (aldesleukin)
Completed
- Leukemia
- +2 more
- aldesleukin
-
Seattle, WashingtonUniversity of Washington Medical Center
Feb 25, 2019
Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New York, New York
- +4 more
Oct 22, 2018
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Seattle (biological, drug, procedure, radiation)
Terminated
- Leukemia
- +4 more
- anti-thymocyte globulin
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
May 19, 2017